Calliditas hits $90m jackpot as biotech IPO craze continuesSwedish biotech Calliditas has raised $90 million in an upsized US IPO and private placement, valuing the rare kidney and liver disease Share XCalliditas hits $90m jackpot as biotech IPO craze continueshttps://pharmaphorum.com/news/calliditas-hits-90m-jackpot-as-biotech-ipo-craze-continues/